Drug Patent Watch
MAY 18, 2024
ADASUVE (loxapine) Alexza pharms Patent: 9,370,629 Expiration: May 20, 2024 See More … For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.
Collaborative Drug
MAY 18, 2024
Upcoming Webinar: Targeted Protein Degradation - New Modalities and Design Technologies
Drugs.com
MAY 18, 2024
SATURDAY, May 18, 2024 -- People with seasonal allergies often turn to over-the-counter and prescription medicines to relieve symptoms like coughing, sneezing, runny nose, congestion and itchy eyes, nose or throat.But they often aren’t aware that.
Drug Patent Watch
MAY 18, 2024
Annual Drug Patent Expirations for EQUETRO Equetro is a drug marketed by Validus Pharms and is included in one NDA. It is available from one supplier.
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
Drug Patent Watch
MAY 18, 2024
This chart shows the pharmaceutical companies with the most suppository dosed drugs. For a different perspective, see the most popular dosage types.
Drug Patent Watch
MAY 18, 2024
Annual Drug Patent Expirations for ULESFIA Ulesfia is a drug marketed by Shionogi Inc and is included in one NDA.
Expert insights. Personalized for you.
64 
Let's personalize your content